The effect of cyclooxygenase-2 expression on tumor vascularity in advanced stage ovarian serous carcinoma

Cancer

Volumn 98, Issue 7, 2003, Pages 1423-1429

  Ali Fehmi, Rouba ^a   Che, Mingxin ^a   Khalifeh, Ibrahim ^a   Malone, John M ^a   Morris, Robert ^a   Lawrence, W Dwayne ^b   Munkarah, Adnan R ^a,c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

Angiogenesis; Cyclooxygenase 2; Immunohistochemistry; Ovarian carcinoma

Indexed keywords

CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; MOLECULAR MARKER; PROTEIN BCL 2; PROTEIN P53;

ADULT; ADVANCED CANCER; AGED; ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CELL PROLIFERATION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; ONCOGENE NEU; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; TUMOR VASCULARIZATION;

ADULT; AGED; BIOPSY, NEEDLE; COHORT STUDIES; CYSTADENOMA, SEROUS; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; PROBABILITY; PROGNOSIS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0141675101     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11650     Document Type: Article

References (24)

1. Masunaga R, Kohno H, Dhar DK, et al. Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients. Clin Cancer Res. 2000;6:4064-4068.
2. Uefuji K, Ichikura T, Mochizuki H. Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer. Clin Cancer Res. 2000;6:135-138.
3. Gallo O, Franchi A, Magnell L, et al. Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis. Neoplasia. 2001;3:51-61.
4. Cao QJ, Einstein MH, Anderson PS, Runowicz CD, Balan R, Jones JG. Expression of COX-2, Ki-67, cyclin D1, and P21 in endometrial endometroid carcinomas. Int J Gynecol Pathol. 2002;21:147-154.
5. Kulkami S, Rader JS, Zhang F, et al. Cyclooxygenase-2 is overexpressed in human cervical cancer. Clin Cancer Res. 2001;7:429-434.
6. Giovannucci E, Egan KM, Hunter DJ, et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med. 1995;333:609-614.
7. Rosenberg L, Palmer JR, Rao RS, et al. A case-control study of analgesic use and ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2000;9:933-937.
8. Cibere J, Sibley J, Haga M. Rheumatoid arthritis and the risk of malignancy. Arthritis Rheum. 1997;40:1580-1586.
9. Munkarah AR, Morris R, Baumann P, et al. Effects of prostaglandin E(2) on proliferation and apoptosis of epithelial ovarian cancer cells. J Soc Gynecol Investig. 2002;9:168-173.
10. Coffey RJ, Hawkey CJ, Damstrup L, et al. Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins and mitogenesis in polarizing colon cancer cells. Proc Natl Acad Sci U S A. 1997;94:657-662.
11. Vadlamudi R, Mandal M, Adam L, Steinbach G, Mendelsohn J, Kumar R. Regulation of cyclooxygenase-2 pathway by HER2 receptor. Oncogene. 1999;18:305-314.
12. Form DM, Auerbach R. PGE2 and angiogenesis. Proc Soc Exp Biol Med. 1983;172:214-218.
13. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 1998;93:705-716.
14. Matsumoto Y, Ishiko O, Deguchi M, Nakagawa E, Ogita S. Cyclooxygenase-2 expression in normal ovaries and epithelial ovarian neoplasms. Int J Mol Med. 2001;8:31-36.
15. DuBois RN, Awad J, Morrow J, Roberts LJ, Bishop PR. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester. J Clin Invest. 1994;93:493-498.
16. Ferrandina G, Ranelletti FO, Lauriola L, et al. Cyclooxygenase-2 (COX), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer. Gynecol Oncol. 2002;85:305-310.
17. Krishna M, Smith TW, Recht LD. Expression of bcl-2 in reactive and neoplastic astrocytes: lack of correlation with presence or degree of malignancy. J Neurosurg. 1995;83:1017-1022.
18. Kawabe A, Shimada Y, Uchida S, et al. Expression of cyclooxygenase-2 in primary and remnant gastric carcinoma: comparing it with p53 accumulation, Helicobacter pylori infection, and vascular endothelial growth factor expression. J Surg Oncol. 2002;80:79-88.
19. Kawabe A, Shimada Y, Uchida S, et al. Expression of cyclooxygenase-2 is associated with carcinogenesis of the lower part of thoracic esophageal squamous cell carcinoma and p53 expression. Oncology. 2002;62:46-54.
20. Shigemasa K, Tian X, Gu L, Shiroyama Y, Nagai N, Ohama K. Expression of cyclooxygenase-2 and its relationship to P53 accumulation in ovarian adenocarcinomas. Int J Oncol. 2003;22:99-105.
21. Shono T, Tofilon PJ, Bruner JM, Owolabi O, Lang FF. Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations. Cancer Res. 2001;61:4375-4381.
22. Sakuma K, Fujimori T, Hirabayashi K, Terano A. Cyclooxygenase (COX)-2 immunoreactivity and relationship to p53 and Ki-67 expression in colorectal cancer. J Gastroenterol. 1999;34:189-194.
23. Denkert C, Kobel M, Pest S, et al. Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma. Am J Pathol. 2002;160:893-903.
24. Dore M, Cote L, Mitchell A, Sirios J. Expression of prostaglandin G/H synthase type 1, but not type 2, in human ovarian adenocarcinoma. J Histochem Cytochem. 1998;46:77-84.